TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Cervical cancer elimination

Key Statistics

  • <4/100,000 — Who elimination threshold
  • 90–70–90 — 2030 Targets: Vaccination–screening–treatment
  • 348,874 — Global cervical cancer deaths, 2022

Don't-miss facts

  1. Elimination = <4/100,000; WHO 2030 targets 90% vaccinated – 70% screened – 90% treated

  2. 12 high-risk HPV types; 16/18 cause ~70% of cancers; single-dose nonavalent/bivalent vaccine (KEN-SHE, 97.5% efficacy) – NHS single-dose since Sept 2023

  3. HPV primary testing sensitivity 89.9% vs cytology 72.9% for high-grade disease (ESTAMPA: cytology missed 52% of CIN3+ vs HPV 2%)

  4. UK screening coverage 68.7% and falling; multi-level inequity in uptake (socioeconomic, ethnicity, disability, LGBTQ+, age, migrant status)

  5. Self-sampling: YouScreen return 56% (opportunistic) vs 13% (postal); Dutch data show lower HPV/CIN3+ detection with self- vs clinician-sampling – equivalence not proven

  6. LLETZ (excision, 7–25mm) ↑miscarriage/preterm birth (risk rises >10mm depth); ablative methods (cryotherapy, cold coagulation, laser) have no obstetric sequelae

  7. ESTAMPA colposcopy: sensitivity 90.4%/specificity 50.1% for CIN2+, falling to 77.6% postmenopausally; 3 biopsies → 95.6% sensitivity vs 60.6% for 1

  8. ≥50% CIN2 regresses spontaneously in 2 years – conservative management viable in selected women <30y (6-monthly colposcopy up to 2 years)

Vaccine dose vs schedule

Single dose (KEN-SHE, 97.5% efficacy) – NHS standard since 2023 Multi-dose retained: immunocompromised individuals

Screen-triage-treat options (WHO)

Primary HPV test (sensitivity 89.9%) Cytology alone (sensitivity 72.9%, still used in 78% of programmes)

Abbreviation Key

  • WHO — World Health Organization
  • LLETZ — large loop excision of the transformation zone
  • HPV — human papillomavirus
  • AICCS — artificial intelligence cervical cytology system
  • VLP — virus-like particle
  • aOR — adjusted odds ratio
  • CIN — cervical intraepithelial neoplasia
  • RR — relative risk
  • LMIC — low- and middle-income country
  • OR — odds ratio
  • HIC — high-income country
  • CI — confidence interval
  • LBC — liquid-based cytology
  • NHS — National Health Service
  • HC2 — hybrid capture 2 (HPV testing platform)
  • GAVI — Global Alliance for Vaccines and Immunisation (the Vaccine Alliance)
  • VIA — visual inspection with acetic acid
  • UNICEF — United Nations Children's Fund
  • VILI — visual inspection with Lugol's iodine

Source: Davies JC et al. Cervical cancer elimination: what, how and WHO? The Obstetrician & Gynaecologist 2025;27:241–251. doi:10.1111/tog.12984

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free